-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LEO-152020 in Chronic Urticaria Or Hives
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. LEO-152020 in Chronic Urticaria Or Hives Drug Details: LEO-152020 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LEO-152020 in Atopic Dermatitis (Atopic Eczema)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.LEO-152020 in Atopic Dermatitis (Atopic Eczema) Drug Details: LEO-152020 is under development for the treatment of...
-
Product Insights
LEO Pharma – Vernouillet Pharmaceutical Plant – Centre
Equip yourself with the essential tools needed to make informed and profitable decisions with our LEO Pharma - Vernouillet Pharmaceutical Plant - Centre report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Holladay Pptys – The Leo at LaGrotte Square Residential – Indiana
Equip yourself with the essential tools needed to make informed and profitable decisions with our Holladay Pptys - The Leo at LaGrotte Square Residential - Indiana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
LEO Grp/ Voith – Water Pumps Manufacturing Plant – Telangana
Equip yourself with the essential tools needed to make informed and profitable decisions with our LEO Grp/ Voith - Water Pumps Manufacturing Plant - Telangana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Advenir Oakley – Leo at Flint Crossing Apartment Complex – Alabama
Equip yourself with the essential tools needed to make informed and profitable decisions with our Advenir Oakley - Leo at Flint Crossing Apartment Complex - Alabama report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
J Grp/ Leo Homes/ Vfund – Stevenage Residential Building – Hertfordshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our J Grp/ Leo Homes/ Vfund - Stevenage Residential Building - Hertfordshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Sector Analysis
NewThailand Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Thailand Beer and Cider Market Report Overview The Thailand beer and cider market size was LCU163.56 billion in 2022. The market is expected to grow at a CAGR of more than 9% during 2023-2028. Thailand Beer and Cider Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the Thailand Beer and Cider Market Forecast Download A Free Report Sample The Thailand Beer and Cider market research report provides detailed data analysis of the beer and cider sector...
-
Product Insights
Pacific Quang Tri JSC – Mui Leo Beach Resort and Tourism Complex – Quang Tri
Equip yourself with the essential tools needed to make informed and profitable decisions with our Pacific Quang Tri JSC - Mui Leo Beach Resort and Tourism Complex - Quang Tri report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – UNI-50002 in Atopic Dermatitis (Atopic Eczema)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.UNI-50002 in Atopic Dermatitis (Atopic Eczema)Drug Details:Orismilast (UNI-50002 and LEO 32731) is under development for the...
-
Company Profile
![]()
Leo Pharma AS – Company Profile
LEO Pharma AS (LEO Pharma), a subsidiary of LEO Foundation, is a drug manufacturing company. It discovers, develops, manufactures, and commercializes medicines for skin diseases and thrombosis. Its product portfolio spans pharmaceuticals for the treatment of diseases such as eczema, psoriasis, skin infections, actinic keratosis, non-melanoma skin cancer and thrombosis. The company also manufactures and markets products for the treatment of bacterial infections, coagulation, cardiovascular, antibiotics, nutritional disorders, osteoporosis, and renal problems. LEO Pharma markets its products worldwide. The company...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Olorinab in Abdominal Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Olorinab in Abdominal PainDrug Details:Olorinab (APD-371) is under development for the treatment of visceral pain specifically...
-
Track & Monitor
NewFoodservice Venture Capital Investments in Q2 2023
GlobalData's Foodservice VentureView report provides detailed coverage of the global venture capital investment activity in Foodservice industry in Q2 2023, covering key insights and trends.
-
Product Insights
Advenir Oakley/ TruLife Commu – LEO at Bethel Place – Texas
Advenir Oakley/ TruLife Commu – LEO at Bethel Place – Texas involves the construction of 200 units of single-story, residential cottages on 12ha in Weatherford, Texas, the US. The US$30 million project includes the following: 1. Construction of 73m2 one-bedroom units 2. Construction of 105m2 two-bedroom units 3. Construction of 139m2 three-bedroom units ..... more details on the scope of this project are covered in the report. In addition, the project profile includes core details such as project name, stage,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Izuforant in Atopic Dermatitis (Atopic Eczema)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Izuforant in Atopic Dermatitis (Atopic Eczema)Drug Details:Izuforant is under development for the treatment of atopic dermatitis and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LP-0200 in Psoriasis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.LP-0200 in Psoriasis Drug Details:LP-0200 is under development for the treatment of psoriasis. It acts by...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Amyotrophic Lateral Sclerosis in Amyotrophic Lateral Sclerosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amyotrophic Lateral Sclerosis in Amyotrophic Lateral Sclerosis Drug Details: Monoclonal antibody is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Atopic Dermatitis (Atopic Eczema)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Atopic Dermatitis (Atopic Eczema) Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Alopecia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Alopecia Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent. It is formulated as...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Hand Dermatitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Hand Dermatitis Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent. It is formulated...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.